SCHEMBL4691298

SCHEMBL4691298

[C]OCC(Cl)(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15359393 0.72
SCHEMBL787874 0.67
SCHEMBL27315 0.61
SCHEMBL2889249 0.61
SCHEMBL27314 0.61
SCHEMBL23302398 0.61
SCHEMBL766306 0.61
SCHEMBL8390 0.61
SCHEMBL8536220 0.61
SCHEMBL11027918 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537094-A2 METHODS AND COMPOSITIONS FOR CONVERTING TAXANE AMIDES TO PACLITAXEL OR OTHER TAXANES Natural Pharmaceuticals, Inc. (US) 2005-06-08 EP claimed
WO-2004013096-A2 METHODS AND COMPOSITIONS FOR CONVERTING TAXANE AMIDES TO PACLITAXEL OR OTHER TAXANES NATURAL PHARMACEUTICALS INC. (US) 2004-02-12 WO claimed
EP-0773938-A1 SEMI-SYNTHETIC TAXANES WITH ANTI-TUMOURAL ACTIVITY INDENA S.p.A. (IT) 1997-05-21 EP claimed
WO-1996003394-A1 SEMI-SYNTHETIC TAXANES WITH ANTI-TUMOURAL ACTIVITY INDENA S.P.A. (IT) 1996-02-08 WO claimed
US-5142039-A β-lactam antibiotics ELI LILLY AND COMPANY (US) 1992-08-25 US claimed
US-4381300-A Sulphur analogs of cephalosporins having a nucleophile substituted in the 7 position MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1983-04-26 US claimed
US-4265882-A Sulphur analogs of penicillins having a nucleophile substituted in the 6 and 7 position, respectively MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1981-05-05 US claimed
EP-0000800-B1 SELECTIVE N-PROTECTION OF AMINOGLYCOSIDES AND NOVEL, SELECTIVELY PROTECTED AMINOGLYCOSIDE INTERMEDIATES Technobiotic Ltd. (CH) 1980-12-10 EP claimed
US-4066752-A 1-Desamino-1-hydroxy and 1-desamino-1-epi-hydroxy-4,6-di-o-(aminoglycosyl)-1,3-diaminocyclitols; 1-desamino-1-oxo-4,6-di-o-(aminoglycosyl)-1,3-diaminocyclitols, intermediates and use as antibacterial agents SCHERING CORPORATION (US) 1978-01-03 US claimed
EP-1730112-B1 3-((HETERO)ARYLSULFONYL)-8'[ (AMINOALKYL)OXY]QUINOLINES AS 5-HT6 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CNS DISORDERS GLAXO GROUP LTD (GB) 2008-09-03 EP disclosed
EP-1289998-A1 NEW PROCESS FOR THE PREPARATION OF VINYL-PYRROLIDINONE CEPHALOSPORINE DERIVATIVES Basilea Pharmaceutica AG (CH) 2003-03-12 EP disclosed
WO-2001090111-A1 NEW PROCESS FOR THE PREPARATION OF VINYL-PYRROLIDINONE CEPHALOSPORINE DERIVATIVES BASILEA PHARMACEUTICA AG (CH) 2001-11-29 WO disclosed
US-5580976-A AZETIDINONE CHEMICAL INTERMEDIATE, USEFUL FOR PREPARING ANTIBIOTICS SHIONOGI & CO., LTD. (JP) 1996-12-03 US disclosed
US-5563264-A Preparation of βlactam compounds SHIONOGI & CO., LTD. (JP) 1996-10-08 US disclosed
US-5462952-A Have activity as inhibitors of 5-lipoxygenase and/or cyclooxygenase WARNER-LAMBERT COMPANY (US) 1995-10-31 US disclosed
EP-0611115-A1 Preparation of beta-lactam compounds, and intermediates therefor SHIONOGI & CO., LTD. (JP) 1994-08-17 EP disclosed
US-5066668-A Enzyme inhibitors, cyclooxygenase and lipoxygenase, mixture with nonsteroid antiinflammatory agent WARNER-LAMBERT CO. (US) 1991-11-19 US disclosed
EP-0401857-A2 Fenamate 1,3,4-thiadiazoles and 1,3,4-oxadiazoles as antiinflammatory agents WARNER-LAMBERT COMPANY (US) 1990-12-12 EP disclosed
US-4962119-A Inhibit lipoxygenase, cyclooxygenase WARNER-LAMBERT COMPANY (US) 1990-10-09 US disclosed
EP-0070204-A2 Carboxylic beta-lactam compounds and the preparation thereof SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1983-01-19 EP disclosed